PAT OHENHEN: Open Payments
NPI 1679112437 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 24 payments from 10 companies in 2025. Trend: 2023 $386 · 2024 $876 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $126 |
| AstraZeneca Pharmaceuticals LP | 5 | $107 |
| Novo Nordisk Inc | 4 | $58 |
| Lilly USA, LLC | 3 | $58 |
| ABBVIE INC. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Viatris Specialty LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: Korlym, AIRSUPRA, JARDIANCE, UBRELVY, Wegovy, MOUNJARO, FARXIGA, YUPELRI.
Industry payments across NC — which companies pay providers there.
